Ten patient groups oppose REGROW Act that would gut stem cell oversight

michael-j.-fox-foundation

The REGROW Act would drastically weaken FDA regulation of experimental stem cell therapies. I’ve criticized it in numerous posts (see those here) for its radical ideas that would put patients and the stem cell field at risk. I’m not the only one concerned about it as both ARM and ISSCR oppose it too. Now 10 top patient advocacy …

Ten patient groups oppose REGROW Act that would gut stem cell oversight Read More »